Coverage with evidence development, only in research, risk sharing or patient access scheme? A framework for coverage decisions

Research output: Book/ReportOther report


Until recently, purchasers’ options regarding whether to pay for the use of technologies have been binary in nature: a treatment is covered or not covered. However, policies have emerged which expand the options - for example, linking coverage to evidence development, an option increasingly used for new treatments with limited/uncertain evidence. There has been little effort to reconcile the features of technologies with the available options in a way that reflects purchasers’ ranges of authority
Original languageEnglish
Place of PublicationYork UK
PublisherCentre for Health Economics, University of York
Number of pages40
Publication statusPublished - Apr 2012

Publication series

NameCHE Research Paper
PublisherCentre for Health Economics, University of York


  • health technology assessment
  • cost effectiveness
  • comparative effectiveness
  • only in research
  • coverage with evidence development
  • patient access scheme

Cite this